[In the Media] “Japan should follow US efforts to develop new antibiotics” (NIKKEI ASIA, July 10, 2021)
date : 8/20/2021
Tags: AMR
On July 10, 2021, Nikkei Asia published an editorial by Mr. Michael W. Hodin, CEO of the Global Coalition on Aging (GCOA), that was written in collaboration with Health and Global Policy Institute (HGPI) – “Japan should follow US efforts to develop new antibiotics.” The editorial discusses the “PASTEUR Act” being proposed in the United States and advocates for greater policy action on the issue of antimicrobial resistance (AMR).
For further information, please see the editorial
Top Research & Recommendations Posts
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Research Report] 2017 Public Survey on Healthcare in Japan
- [Research Report] Public Opinion Survery on the Threat of Antimicrobial Resistance (AMR) (November 26, 2021)
